LFWD posts unaudited Q3 revenue of ~$6.2M, cash ~$2.0M

Rhea-AI Filing Summary

Lifeward Ltd. (LFWD) reported preliminary, unaudited Q3 results for the quarter ended September 30, 2025. The company estimates revenue of approximately $6.2 million and U.S. GAAP operating expenses of about $5.8–$5.9 million for the period.

Liquidity at quarter-end was limited, with cash and cash equivalents of approximately $2.0 million as of September 30, 2025. The company also stated its cash, cash equivalent and short‑term investment balance was approximately $2.0 million as of the same date.

Management prepared these figures and they are subject to customary quarter-end close procedures, which could change the amounts. The company’s independent auditor, EY, has not audited, reviewed, or compiled these results. Actual results will appear in the upcoming Form 10‑Q. The information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.

Insights

Equity research analyst

Preliminary Q3 revenue ~$6.2M; cash ~$2.0M, unaudited.

Lifeward disclosed estimated Q3 revenue of $6.2M and U.S. GAAP operating expenses of $5.8–$5.9M for the quarter ended September 30, 2025. These figures provide an early look at activity but are management-prepared and subject to final close procedures.

Cash and cash equivalents were about $2.0M as of September 30, 2025, and the company also cited a cash, cash equivalent and short-term investment balance of $2.0M. The auditor (EY) has not performed procedures on these estimates.

The disclosure was furnished under Item 2.02, not filed. Actual results will be included in the forthcoming Form 10‑Q; amounts may change after completion of quarter-end review.

false000160796200-0000000Floor 6Yokneam IlitIL+508.251.11544.959.0123Ordinary Shares, par value NIS 0.25NASDAQ00016079622025-10-162025-10-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 16, 2025

Lifeward Ltd.

(Exact Name of Registrant as Specified in its Charter)

Israel		001-36612		Not Applicable
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

200 Donald Lynch Blvd. Marlborough, MA		01752
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +508.251.1154

Not applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Ordinary Shares, par value NIS 1.75		LFWD		Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

Preliminary Financial Results

On October 16, 2025, Lifeward Ltd. (the “Company”) announced its preliminary revenue results of approximately $6.2 million for the quarter ended September 30, 2025 and its preliminary U.S. GAAP operating expenses in the range of approximately $5.8 million to $5.9 million. The Company’s cash and cash equivalents as of September 30, 2025 was approximately $2.0 million. These unaudited, preliminary amounts have been prepared by and are the responsibility of management. These amounts are based upon information available to management as of the date of this Current Report on Form 8-K and subject to completion of customary quarter-end close procedures and financial review that could result in changes to the amounts. Furthermore, these amounts do not present all information necessary for an understanding of the Company’s financial condition as of September 30, 2025 or its results of operations as of such date. The Company’s independent registered public accounting firm, Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (“EY”), has not audited, reviewed, compiled or performed any procedures with respect to these preliminary financial results and, accordingly, EY does not express an opinion or any other form of assurance with respect thereto. The Company’s actual results for the quarter ended September 30, 2025 will be included in its Quarterly Report on Form 10-Q and may differ materially from the above estimate.

The Company’s cash, cash equivalent and short-term investment balance as of September 30, 2025 is approximately $2.0 million.

The information disclosed in this Item 2.02 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lifeward Ltd.
Dated: October 16, 2025	By:	/s/ Almog Adar
	Name:	Almog Adar
	Title:	Chief Financial Officer

FAQ

What preliminary Q3 2025 revenue did Lifeward (LFWD) report?

Lifeward estimates approximately $6.2 million in revenue for the quarter ended September 30, 2025.

What were Lifeward’s preliminary operating expenses for Q3 2025?

U.S. GAAP operating expenses are estimated at approximately $5.8–$5.9 million for the quarter.

How much cash did Lifeward have at quarter-end Q3 2025?

Cash and cash equivalents were approximately $2.0 million as of September 30, 2025.

Are Lifeward’s preliminary results audited or reviewed by EY?

No. EY has not audited, reviewed, or compiled the preliminary results.

Where will Lifeward’s final Q3 2025 results be reported?

Final results will be included in the company’s upcoming Form 10‑Q.

Is this disclosure considered filed under the Exchange Act?

No. The information was furnished under Item 2.02 and is not deemed filed.